Endoscopy 2025; 57(S 02): S163-S164
DOI: 10.1055/s-0045-1805415
Abstracts | ESGE Days 2025
Oral presentation
Upper GI endoscopy – A Deep Dive 05/04/2025, 10:30 – 11:30 Room 124+125

Device-assisted Enteroscopy: An Irish Experience

Authors

  • C Costigan

    1   Tallaght University Hospital, Dublin, Ireland
    2   Trinity Academic Gastroenterology Group, Trinity College, Dublin, Ireland

  • R Connaughton

    3   Connolly Hospital Blanchardstown, Dublin, Ireland

  • S sihag

    1   Tallaght University Hospital, Dublin, Ireland

  • E Leung

    1   Tallaght University Hospital, Dublin, Ireland

  • F O'Hara

    1   Tallaght University Hospital, Dublin, Ireland

  • B Hall

    3   Connolly Hospital Blanchardstown, Dublin, Ireland

  • D McNamara

    1   Tallaght University Hospital, Dublin, Ireland
    2   Trinity Academic Gastroenterology Group, Trinity College, Dublin, Ireland
Further Information
Also available at
 

Aims Device-assisted enteroscopy (DAE) was introduced in 2011 has seen a rapid increase in demand. ESGE DAE KPIs have been published as well as a recent UK-wide (DEEP-UK) review. In this study we aim to compare national performance measures for DAE in Ireland with the recommended ESGE quality standards.

Methods DAE data from endoscopy and clinical systems at Tallaght (TUH) and Connolly (CH) Hospitals from 2015 to 2024 was retrospectively collated.

Results 1,014 DAE studies [840 (79%) TUH, 174 (21%) CH] were identified, 70 (9%) were excluded. 798 (85%) were index procedures, 547 (58%) were male, mean age 61. Double-balloon enteroscopes were used in 864 (92%), 744 (79%) were anterograde (ADBE) and 197 (21%) retrograde (RDBE). Mean depth of insertion was; ADBE:201cm+/-101cm, RDBE:101cm+/-67cm. The majority 864 (92%) were performed using conscious sedation; median doses of midazolam and fentanyl were 5mg ' 75mg respectively, with a mean comfort score=1.45+/-0.67. The overall diagnostic yield was 67% (632 studies).Therapeutic intervention was performed in 375 (40%),98% successfully, while 57/63 (90%) of detected lesions were tattooed. Significant AEs occurred in 1% [1] [2] [3]. Major KPIs (result/target) were: Appropriate indication (94%/95%), depth of insertion tattoo (75%/80%), lesion detection (67%/50%), lesion marking (90%/95%) and complications (3.5%/<5%). All minor KPIs were met. KPIs were consistent between both high-volume(> 50/year) Irish-centres and were comparable to the 3 high-volume UK-centres, all of which performed better than lower-volume UK-centres. GA use was more frequent in the UK, where conscious sedation was associated with poorer outcomes albeit more frequently used in low-volume centres.

Conclusions DAE requirement is increasing. Our study suggests a high-volume model can both ensures compliance with international KPIs and maintains adequate patient comfort with conscious sedation.



Publication History

Article published online:
27 March 2025

© 2025. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany